rs35116188
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 1P and 11B. PP2BP4_ModerateBP6BS1BS2
The NM_080680.3(COL11A2):c.706C>T(p.Pro236Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000841 in 1,613,940 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_080680.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL11A2 | NM_080680.3 | c.706C>T | p.Pro236Ser | missense_variant | 5/66 | ENST00000341947.7 | NP_542411.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL11A2 | ENST00000341947.7 | c.706C>T | p.Pro236Ser | missense_variant | 5/66 | 5 | NM_080680.3 | ENSP00000339915.2 | ||
COL11A2 | ENST00000395194.1 | c.706C>T | p.Pro236Ser | missense_variant | 5/5 | 1 | ENSP00000378620.1 | |||
COL11A2 | ENST00000374708.8 | c.706C>T | p.Pro236Ser | missense_variant | 5/64 | 5 | ENSP00000363840.4 | |||
COL11A2 | ENST00000682718.1 | n.523C>T | non_coding_transcript_exon_variant | 4/6 |
Frequencies
GnomAD3 genomes AF: 0.000408 AC: 62AN: 152050Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000342 AC: 86AN: 251494Hom.: 0 AF XY: 0.000316 AC XY: 43AN XY: 135920
GnomAD4 exome AF: 0.000886 AC: 1295AN: 1461890Hom.: 2 Cov.: 31 AF XY: 0.000861 AC XY: 626AN XY: 727248
GnomAD4 genome AF: 0.000408 AC: 62AN: 152050Hom.: 0 Cov.: 31 AF XY: 0.000417 AC XY: 31AN XY: 74266
ClinVar
Submissions by phenotype
not provided Uncertain:4Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 07, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 25, 2017 | The p.Pro236Ser variant (rs35116188) has not been reported in the medical literature nor has it been previously identified in our laboratory. The p.Pro236Ser variant is listed in the Genome Aggregation Database (gnomAD) browser with an allele frequency of 0.074% in the non-Finnish European population (identified in 94 out of 126,692 chromosomes), and is classified as a variant of uncertain significance in ClinVar (Variant ID: 388231). The proline at codon 236 is highly conserved considering 11 species up to giant panda (Alamut software v2.9), but computational analyses predict conflicting effects of this variant on protein structure/function (SIFT: tolerated, PolyPhen2: benign, MutationTaster: disease causing). Based on the available information, the clinical significance of the p.Pro236Ser variant cannot be determined with certainty. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 02, 2018 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 25, 2016 | The p.Pro236Ser variant in COL11A2 has not been previously reported in individua ls with hearing loss, but has been identified in 0.1% (38/66740) of European chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs35116188). Although this variant has been seen in the general popula tion, its frequency is not high enough to rule out a pathogenic role. Proline (P ro) at position 236 is not conserved in mammals or evolutionarily distant specie s and one mammal (Bushbaby) carries a Serine (Ser), raising the possibility that this change may be tolerated. Additional computational prediction tools do not provide strong support for or against an impact to the protein. In summary, th e clinical significance of the p.Pro236Ser variant is uncertain. - |
Connective tissue disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Human Genetics, Inc, Center for Human Genetics, Inc | Nov 01, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at